Barclays
TNYA icon

Barclays’s Tenaya Therapeutics TNYA Stock Holding History

Barclays’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$12.3K Buy
20,375
+7,230
+55% +$5.28K ﹤0.01% 4806
2026
Q2 		$9.7K Buy
13,145
+2,368
+22% +$1.8K ﹤0.01% 4698
2026
Q1 		$7.46K Sell
10,777
-174,224
-94% -$129K ﹤0.01% 4736
2025
Q4 		$132K Buy
185,001
+185,000
+18,500,000% +$252K ﹤0.01% 4496
2025
Q3 		$2 Sell
1
-9,536
-100% -$9.6K ﹤0.01% 5445
2025
Q2 		$5.83K Sell
9,537
-50,135
-84% -$25.5K ﹤0.01% 4958
2025
Q1 		$34K Sell
59,672
-24,955
-29% -$24.6K ﹤0.01% 4694
2024
Q4 		$121K Sell
84,627
-184,837
-69% -$414K ﹤0.01% 4546
2024
Q3 		$520K Sell
269,464
-4,022
-1% -$11.4K ﹤0.01% 3751
2024
Q2 		$848K Sell
273,486
-527
-0.2% -$2.18K ﹤0.01% 2699
2024
Q1 		$1.43M Buy
274,013
+207,618
+313% +$993K ﹤0.01% 2841
2023
Q4 		$215K Sell
66,395
-183,163
-73% -$395K ﹤0.01% 4384
2023
Q3 		$636K Buy
249,558
+240,436
+2,636% +$1.01M ﹤0.01% 2643
2023
Q2 		$53.5K Sell
9,122
-20,877
-70% -$121K ﹤0.01% 3811
2023
Q1 		$85.5K Buy
29,999
+14,720
+96% +$41.4K ﹤0.01% 4262
2022
Q4 		$30.7K Buy
15,279
+6,319
+71% +$15.4K ﹤0.01% 4714
2022
Q3 		$26K Buy
8,960
+7,558
+539% +$35.3K ﹤0.01% 3984
2022
Q2 		$8K Sell
1,402
-3,240
-70% -$26.2K ﹤0.01% 4702
2022
Q1 		$55K Buy
+4,642
New +$56.2K ﹤0.01% 4082

Other funds holding TNYA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
Mirador Capital Partners
Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return
Almanack Investment Partners
Almanack Investment Partners Wayne, Pennsylvania $833M AUM 25.48% 1-Year Est. Return
RS
R Squared Central, Hong Kong $188M AUM 18.2% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
BridgePort Financial Solutions
BridgePort Financial Solutions Fairfield, Iowa $429M AUM 16.16% 1-Year Est. Return
Citizens Financial Group
Citizens Financial Group Providence, Rhode Island $8.58B AUM 20.32% 1-Year Est. Return

Barclays's TNYA Position: Q3 2026 in Review

Barclays increased its Tenaya Therapeutics (TNYA) stake by 55% in Q3 2026, buying an estimated $5.28K and bringing the position to 20,375 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4806.

Barclays first reported a position in TNYA in Q1 2022 and has held it in 19 quarters since. The position peaked at $1.43M in Q1 2024. 28 funds tracked by Wall St. Rank hold TNYA as of Q3 2026.

  • Barclays held 20,375 shares of Tenaya Therapeutics worth $12.3K as of Q3 2026.
  • Barclays bought 7,230 Tenaya Therapeutics shares in Q3 2026, an estimated $5.28K.
  • Tenaya Therapeutics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4806 holding.
  • Barclays first reported a position in Tenaya Therapeutics in Q1 2022 and has held it in 19 quarters since.
  • Barclays's Tenaya Therapeutics position peaked at $1.43M in Q1 2024.
  • 28 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.